Published in Eur Respir J on February 01, 2008
Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med (2011) 2.77
Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int (2015) 1.90
No detectable association between frequency of marijuana use and health or healthcare utilization among primary care patients who screen positive for drug use. J Gen Intern Med (2013) 1.49
Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Int J Cancer (2014) 1.34
The analgesic potential of cannabinoids. J Opioid Manag (2010) 1.16
Risky health behavior among adolescents in the childhood cancer survivor study cohort. J Pediatr Psychol (2012) 1.12
Update in lung cancer 2008. Am J Respir Crit Care Med (2009) 1.11
Chronic adolescent marijuana use as a risk factor for physical and mental health problems in young adult men. Psychol Addict Behav (2015) 1.00
Dimensions and severity of marijuana consequences: development and validation of the Marijuana Consequences Questionnaire (MACQ). Addict Behav (2012) 0.95
Psychiatric, psychosocial, and physical health correlates of co-occurring cannabis use disorders and nicotine dependence. Drug Alcohol Depend (2013) 0.93
Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg (2008) 0.93
An epidemiologic review of marijuana and cancer: an update. Cancer Epidemiol Biomarkers Prev (2015) 0.87
Marijuana Legalization: Impact on Physicians and Public Health. Annu Rev Med (2015) 0.86
Urinary concentrations of PAH and VOC metabolites in marijuana users. Environ Int (2015) 0.85
Doubts about the role of cannabis in causing lung cancer. Eur Respir J (2008) 0.82
Alcohol and Marijuana Use and Treatment Nonadherence Among Medically Vulnerable Youth. Pediatrics (2015) 0.81
Medical marijuana and driving: a review. J Med Toxicol (2014) 0.80
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity. Ther Adv Neurol Disord (2012) 0.80
The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ (2008) 0.79
Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med (2016) 0.79
"Bong lung" in cystic fibrosis: a case report. J Med Case Rep (2010) 0.78
Cannabis: the next villain on the lung cancer battlefield? Eur Respir J (2008) 0.78
Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci (2015) 0.78
Legalizing Cannabis: A physician's primer on the pulmonary effects of marijuana. Curr Respir Care Rep (2014) 0.77
Severe multisystem dysfunction in a case of high level exposure to smoked cannabis. BMJ Case Rep (2009) 0.76
Cannabis Smoking in 2015: A Concern for Lung Health? Chest (2015) 0.76
Cannabis and lung cancer. Eur Respir J (2008) 0.75
Effect of cannabis smoking on lung function and respiratory symptoms: a structured literature review. NPJ Prim Care Respir Med (2016) 0.75
Anterior mediastinal mass in a young marijuana smoker: a rare case of small-cell lung cancer. Case Rep Med (2012) 0.75
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids. Front Oncol (2017) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
MORTALITY IN RELATION TO SMOKING: TEN YEARS' OBSERVATIONS OF BRITISH DOCTORS. Br Med J (1964) 28.21
Adverse effects of cannabis. Lancet (1998) 4.58
Early age at smoking initiation and tobacco carcinogen DNA damage in the lung. J Natl Cancer Inst (1999) 2.88
Cannabinoids: potential anticancer agents. Nat Rev Cancer (2003) 2.87
The natural history of lung cancer: a review based on rates of tumour growth. Br J Dis Chest (1979) 2.76
Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med (1988) 2.72
Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst (1998) 2.34
Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2006) 2.32
Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest (1997) 2.28
Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med (1998) 1.86
Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ (1986) 1.59
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol (2000) 1.44
Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis (1987) 1.34
Cannabinoids and cancer: causation, remediation, and palliation. Lancet Oncol (2005) 1.23
Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol (2006) 1.18
A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control (2002) 1.12
Clinical consequences of marijuana. J Clin Pharmacol (2002) 1.11
Tar, CO and delta 9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav (1991) 1.10
Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer. Cancer Res (2001) 1.09
Chronic inhalation of marijuana and tobacco in dogs: pulmonary pathology. Res Commun Chem Pathol Pharmacol (1976) 1.04
A comparison of tar, carbon monoxide and pH levels in smoke from marihuana and tobacco cigarettes. Can J Public Health (1983) 1.03
Risk of lung cancer and past use of cannabis in Tunisia. J Thorac Oncol (2006) 1.00
[Etiologic factors in primary bronchial carcinoma in Tunisia]. Tunis Med (1993) 0.93
Mutagenic activity of marihuana smoke condensates. Cancer Lett (1979) 0.92
Lung and aero-digestive cancers in young marijuana smokers. Tumori (1999) 0.89
Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs (1995) 0.88
A cytologic evaluation of sputum in marijuana smokers. J Fam Pract (1994) 0.86
Cytomorphologic features of sputum samples from marijuana smokers. Diagn Cytopathol (1991) 0.83
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J (1995) 13.01
Naturally occurring antibodies devoid of light chains. Nature (1993) 7.35
Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet (1989) 5.82
End of the New Zealand asthma mortality epidemic. Lancet (1995) 4.88
Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology (2000) 4.31
Informed consent: recall by patients tested postoperatively. Ann Thorac Surg (1976) 4.13
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol (1999) 3.87
Competency development in public health leadership. Am J Public Health (2000) 3.84
Tranquillizers. Br Med J (1962) 3.75
Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax (2009) 3.72
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
A glucagonoma syndrome. Lancet (1974) 3.56
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax (1991) 3.39
Beta agonists and asthma mortality: déjà vu. Clin Exp Allergy (1991) 3.39
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study. Lancet (2003) 3.34
Worldwide worsening wheezing--is the cure the cause? Lancet (1992) 3.30
In vivo gene expression profile analysis of human breast cancer progression. Cancer Res (1999) 3.19
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records. BMJ (1998) 3.15
The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials (1993) 3.06
How much asthma is really attributable to atopy? Thorax (1999) 3.04
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax (1990) 3.02
COPD prevalence in a random population survey: a matter of definition. Eur Respir J (2007) 2.97
Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res (2001) 2.85
Guidelines for the diagnosis and management of migraine in clinical practice. Canadian Headache Society. CMAJ (1997) 2.83
Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med (1999) 2.74
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis (2005) 2.65
The self-administration of inhaled beta agonist drugs during severe asthma. N Z Med J (1990) 2.61
Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril (1998) 2.57
Personal factors as a cause of differences in prescribing by general practitioners. Br J Prev Soc Med (1968) 2.38
Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J (2009) 2.37
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax (2010) 2.36
Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell (2001) 2.33
Pre-hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Intern Med J (2010) 2.27
Analysis of symptoms of patients with headaches and their response to treatment with ergot derivatives. Q J Med (1968) 2.19
Epidemiology of pneumothorax in England. Thorax (2000) 2.18
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol (1997) 2.15
Repair systems in Saccharomyces. Mutat Res (1974) 2.14
Learning preferences and learning styles: a study of Wessex general practice registrars. Br J Gen Pract (2001) 2.11
Proportional classifications of COPD phenotypes. Thorax (2008) 2.10
Beta-agonist therapy and asthma mortality in Japan. Lancet (1998) 2.06
Baseline risk for asthma deaths. N Z Med J (1992) 2.02
Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J (2009) 1.99
Perinatal factors and atopic disease in childhood. Clin Exp Allergy (1997) 1.96
The defeat of reason. Health Care Anal (1997) 1.96
Placental failure in mice lacking the homeobox gene Dlx3. Proc Natl Acad Sci U S A (1999) 1.96
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax (2005) 1.95
Is infant immunization a risk factor for childhood asthma or allergy? Epidemiology (1997) 1.94
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol (1992) 1.92
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax (1989) 1.87
Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort. Clin Exp Allergy (2010) 1.79
Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart (2008) 1.78
Fatal D.D.T. Poisoning. Br Med J (1945) 1.78
Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol Pharmacol (2000) 1.76
Exploring the scope for advocacy by paediatricians. Arch Dis Child (1999) 1.74
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three. Clin Exp Allergy (2013) 1.72
The future for practice nurses. Br J Gen Pract (1990) 1.70
Dopamine receptors in the central thermoregulatory pathways of the rat. J Physiol (1978) 1.70
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta-analysis. Clin Exp Allergy (2011) 1.68
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. BMJ (2001) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med (1996) 1.66
Symptoms of low blood pressure: a population study. BMJ (1990) 1.66
Structural instability of human tandemly repeated DNA sequences cloned in yeast artificial chromosome vectors. Nucleic Acids Res (1990) 1.64
International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax (2000) 1.64
Systematic review of the dose-response relation of inhaled fluticasone propionate. Arch Dis Child (2004) 1.62
The squalestatins: inhibitors of squalene synthase. Enzyme inhibitory activities and in vivo evaluation of C3-modified analogues. J Med Chem (1996) 1.62
The clinical and immunological effects of pulse methylprednisolone therapy in rheumatoid arthritis. I. Clinical effects. J Rheumatol (1988) 1.60
Trends by anatomic site in the incidence of cutaneous malignant melanoma in Canada, 1969-93. Cancer Causes Control (1999) 1.58
Response to Kopans. Online J Curr Clin Trials (1993) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Self efficacy as a mediator of the relationship between pain intensity, disability and depression in chronic pain patients. Pain (1999) 1.54
What do we need for robust, quantitative health impact assessment? J Public Health Med (2001) 1.52
Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis. Br Med J (1966) 1.52
Impact of nutritional status on DRG length of stay. JPEN J Parenter Enteral Nutr (1987) 1.51
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med (1992) 1.51
Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma. Clin Exp Allergy (2004) 1.51
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur Respir J (2004) 1.50
Impact of psychiatric services on prison suicide. Lancet (1991) 1.50
Case-control study of salmeterol and near-fatal attacks of asthma. Thorax (1998) 1.49
The effect of measurement error on the determination of Helicobacter pylori prevalence. Epidemiology (1997) 1.49
Is allergen exposure the major primary cause of asthma? Thorax (2000) 1.48
Nuclear isomers in superheavy elements as stepping stones towards the island of stability. Nature (2006) 1.48
The effect of the increased prescription charges on the collection of asthma drugs. N Z Med J (1992) 1.48
A study of the management of asthma in a hospital emergency department. N Z Med J (1989) 1.47